The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a long wait for human organ transplants.

A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be part of a small pilot study of a highly experimental treatment.

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ transplant.

US-based woman, Towana Looney, passed a major milestone on Saturday by becoming the longest-living recipient of a pig organ transplant. She is healthy and full of energy with her new kidney for 61 days and counting.

Towana Looney, an Alabama woman who received a gene-edited pig kidney transplant, has surpassed two months post-surgery, making her the longest living recipient of such a transplant.

The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in cross-species transplantation.

The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into patients with kidney failure.